Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ruhnke

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Yeast (Chichester, England)|July 20, 2010
The quorum-sensing molecule E,E-farnesol--its variable secretion and its impact on the growth and metabolism of Candida speciesK Weber, B Schulz, M Ruhnke
Mycoses|August 26, 2009
Resveratrol and its antifungal activity against Candida speciesK Weber, B Schulz, M Ruhnke
Arzneimittel-Forschung|May 1, 1990
Penetration of ciprofloxacin into the spinal fluid in patients with viral and bacterial meningitisM Trautmann, M Ruhnke, K Borner
The Journal of Antimicrobial Chemotherapy|August 10, 2000
Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDSM Ruhnke, A Schmidt-Westhausen, J Morschhäuser
Antimicrobial Agents and Chemotherapy|March 1, 1997
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infectionM Ruhnke, A Schmidt-Westhausen, M Trautmann
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infectionM Ruhnke, A Adler, F M Müller
Mycoses|January 1, 1996
[Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection]M Ruhnke, A Schmidt-Westhausen, M Trautmann
Mycoses|July 8, 1999
Identification of CARE-2-negative Candida albicans isolates as Candida dubliniensisJ Morschhäuser, M Ruhnke, S Michel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 7, 2007
Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensisM Fleischhacker, C Radecke, B Schulz, et al.
Journal of Clinical Microbiology|March 5, 2010
Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistanceM Fleischhacker, J Pasligh, G Moran, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Yeast (Chichester, England)|July 20, 2010
The quorum-sensing molecule E,E-farnesol--its variable secretion and its impact on the growth and metabolism of Candida speciesK Weber, B Schulz, M Ruhnke
Mycoses|August 26, 2009
Resveratrol and its antifungal activity against Candida speciesK Weber, B Schulz, M Ruhnke
Arzneimittel-Forschung|May 1, 1990
Penetration of ciprofloxacin into the spinal fluid in patients with viral and bacterial meningitisM Trautmann, M Ruhnke, K Borner
The Journal of Antimicrobial Chemotherapy|August 10, 2000
Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDSM Ruhnke, A Schmidt-Westhausen, J Morschhäuser
Antimicrobial Agents and Chemotherapy|March 1, 1997
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infectionM Ruhnke, A Schmidt-Westhausen, M Trautmann
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infectionM Ruhnke, A Adler, F M Müller
Mycoses|January 1, 1996
[Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection]M Ruhnke, A Schmidt-Westhausen, M Trautmann
Mycoses|July 8, 1999
Identification of CARE-2-negative Candida albicans isolates as Candida dubliniensisJ Morschhäuser, M Ruhnke, S Michel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 7, 2007
Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensisM Fleischhacker, C Radecke, B Schulz, et al.
Journal of Clinical Microbiology|March 5, 2010
Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistanceM Fleischhacker, J Pasligh, G Moran, et al.
Pageof 11